Article No
ANC-187-020
anti-CD38 (human), mAb (AT1)
anti-CD38 (human), mAb (AT1)
Antibodies Primary
Specifications
| Application | FC |
| Article No | ANC-187-020 |
| Country Availability | SE, FI, DK, NO, IS, EE, LV, LT |
| Clone | AT1 |
| Clone Type | monoclonal |
| Conjugation | Unconjugated |
| Description | anti-CD38 (human), mAb (AT1) |
| Supplier | Adipogen Life Sciences |
| Format | Liquid |
| Immunogen | Human T cell tumor cells: CEM. |
| Isotype | IgG1 |
| Notes | Human CD38 is a type II transmembrane glycoprotein with bifunctional ectoenzyme activity catalyzing both synthesis and hydrolysis of cyclic ADP ribose. CD38 is involved in lymphocyte activation and adhesion to endothelium and has been identified as a counter-receptor of CD31.|Monoclonal Antibody. Isotype: Mouse IgG1. Clone: AT1. Applications: FACS. 50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 0.5% Gentamicin sulfate Human CD38 is a type II transmembrane glycoprotein with bifunctional ectoenzyme activity catalyzing both synthesis and hydrolysis of cyclic ADP ribose. CD38 is involved in lymphocyte activation and adhesion to endothelium and has been identified as a counter-receptor of CD31. |
| Alias Names | ADP-ribosyl Cyclase 1; Cyclic ADP-ribose Hydrolase 1; T10 |
| Product Type | Antibodies Primary |
| Research area | Immunology |
| Shipping Information | BLUE ICE |
| Size | 100 µg |
| Source / Host | mouse |
| Species Reactivity | human |
| Stability | Stable for at least 1 year after receipt when stored at +4°C. |
| Storage | 4°C |
| Substrate / Buffer | 50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 0.5% Gentamicin sulfate |
| Technical Specifications | Monoclonal Antibody. Isotype: Mouse IgG1. Clone: AT1. Applications: FACS. 50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 0.5% Gentamicin sulfate Human CD38 is a type II transmembrane glycoprotein with bifunctional ectoenzyme activity catalyzing both synthesis and hydrolysis of cyclic ADP ribose. CD38 is involved in lymphocyte activation and adhesion to endothelium and has been identified as a counter-receptor of CD31. |
| Product Page Updated | 2024-02-01T08:25:01.492Z |
